MNPR

Monopar Therapeutics Inc

NASDAQ · Biotechnology

$57.75

+0.87 (+1.53%)

Small-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

19 analysts

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -28.5% upside

Low Target $22.89

Average Target $41.31

High Target $45.20

Current Price $57.75

Current
$57.75

Target
$41.31

$22.89 $41.31 avg $45.20